Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630445 · ClinicalTrials.gov registry record · NA
Slowly Digestible Carbohydrates and the Ileal Brake
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03630445: Completed NA study, sponsored by Purdue University.
NCT03630445 is a NA study that has completed, run by Purdue University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03630445, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The ileal brake is a feedback mechanism controlling stomach-mediated transit of a meal, for which gastric emptying can be used as an indicator. Previously, slowly digestible carbohydrates (SDCs) were shown to activate the ileal brake in a rat model; the current research aimed to determine the effect of common SDCs in humans.
Primary Outcome
Breath test was performed using 13C-octanoic acid mixed into test meals
Interventions
- OTHER Maltodextrin
- OTHER Isomaltooligosaccharides (IMOs)
- OTHER Xtend® sucromalt
- OTHER Combination of IMOs and Xtend® sucromalt
- OTHER Raw corn starch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-06-02 |
| Est. Completion | 2015-07-31 |
| Phase | NA |
What the finished NCT03630445 record still lists
NCT03630445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Maltodextrin is the first listed.
NCT03630445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03630445 about?
NCT03630445 is a clinical study titled "Slowly Digestible Carbohydrates and the Ileal Brake". The ileal brake is a feedback mechanism controlling stomach-mediated transit of a meal, for which gastric emptying can be used as an indicator. Previously, slowly digestible carbohydrates (SDCs) were shown to activate the ileal brake in a rat model; the current research aimed to determine the effect...
What is the current status of trial NCT03630445?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-06-02. Estimated completion is 2015-07-31.
What interventions are being tested in trial NCT03630445?
The interventions under investigation include: Maltodextrin (OTHER), Isomaltooligosaccharides (IMOs) (OTHER), Xtend® sucromalt (OTHER), Combination of IMOs and Xtend® sucromalt (OTHER), Raw corn starch (OTHER).
Who is sponsoring clinical trial NCT03630445?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03630445's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI